ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 269 • 2019 ACR/ARP Annual Meeting

    Attitudes and Beliefs About Opioid Medications: Determining Treatment Use in Osteoarthritis

    Ernest Vina1, Jazmin Dagnino 1 and C. Kent Kwoh 1, 1University of Arizona, Tucson, AZ

    Background/Purpose: Considering the growing opioid epidemic in the US, it is imperative to have a good understanding of what patient characteristics predict the use of…
  • Abstract Number: 270 • 2019 ACR/ARP Annual Meeting

    Outcomes of a Fracture Liaison Service at an Academic Health Center

    Micah Yu1, Donna Jose 2, Parke Hudson 2, Christina Downey, MD 3, Wesley Phipatanakul 2, Silvana Giannelli 2, Kevin Codorniz 4 and Karina Torralba 5, 1Loma Linda University Medical Center, loma linda, 2Loma Linda University, Loma Linda, 3Loma Linda University Medical Center, Loma LInda, CA, 4[email protected], Loma Linda, 5Loma Linda University School of Medicine, Loma Linda, CA

    Background/Purpose: Osteoporosis is associated with increased morbidity and mortality.  There is a 60% risk of a subsequent fracture for patients who have had one fracture,…
  • Abstract Number: 271 • 2019 ACR/ARP Annual Meeting

    Who Prescribed Which Osteoporosis Medication to Whom

    Jiannong Liu1, Haifebg Guo 1, Tingting Gong 1 and Yi Peng 2, 1Hennepin Healthcare Research Institute, Minneapolis, MN, 2Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN

    Background/Purpose: Several osteoporosis (OP) medicines came on the market in the past two decades, each with its own indications. However, there is no clear information…
  • Abstract Number: 272 • 2019 ACR/ARP Annual Meeting

    Osteoporosis Management Outcomes in a Southern California County Health System

    Lorien Ahn1, Jordan Thompson 1, Nancy Collado 2, Micah Yu 2, Anna Lafian 2, Christina Downey, MD 3 and Karina Torralba 4, 1Loma Linda University, Loma linda, 2Loma Linda University Medical Center, loma linda, 3Loma Linda University Medical Center, Loma LInda, CA, 4Loma Linda University School of Medicine, Loma Linda, CA

    Background/Purpose: Fragility fractures (FF) are a sentinel event in osteoporosis and world-wide only 20% of patients with a FF receive treatment, a large care gap.…
  • Abstract Number: 273 • 2019 ACR/ARP Annual Meeting

    Bone Health in Lupus: Findings from the Southern California Lupus Registry

    Vaneet Sandhu, MBBS1 and Sara Johnson 2, 1Loma Linda University, Loma Linda, CA, 2St George's University, Loma Linda, CA

    Background/Purpose: The association of vitamin D deficiency with SLE is well established. While disease activity can itself cause pathologic bone remodeling and reduced vitamin D,…
  • Abstract Number: 274 • 2019 ACR/ARP Annual Meeting

    Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis

    Dina Jones1, Louise Murphy 2, Ranjita Misra 1, Alison Vargovich 3, Dana Guglielmo 4, Maura Robinson 1, Samantha Shawley-Brzoska 1, Sijin Wen 1, Megan Burkart 1 and Richard Vaglienti 1, 1West Virginia University, Morgantown, WV, 2Centers for Disease Control and Prevention, Division of Population Health, Atlanta, 3University at Buffalo - SUNY, Buffalo, NY, 4Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA

    Background/Purpose: In 2016, 1 in 5 US adults reported chronic pain (CP). Osteoarthritis and rheumatoid arthritis are top causes of CP. The Stanford University Chronic…
  • Abstract Number: 275 • 2019 ACR/ARP Annual Meeting

    Exercise Is Medicine® in Primary Care Practice: Provider Characteristics and Physical Activity Counseling for Patients with Arthritis, DocStyles, 2018

    Dana Guglielmo1, Louise Murphy 2, Kristina Theis 1, Charles Helmick 1, John Omura 3 and Janet Croft 1, 1Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA, 2Centers for Disease Control and Prevention, Division of Population Health, Atlanta, 3Centers for Disease Control and Prevention, Division of Nutrition, Physical Activity, and Obesity, Atlanta, GA

    Background/Purpose: Physical activity (PA) can reduce pain, prevent or delay disability, and improve physical functioning and mood in people with arthritis. However, only 36% of…
  • Abstract Number: 276 • 2019 ACR/ARP Annual Meeting

    Effectiveness of Screening by Nurse with Predetermined Questionnaire on Infections Before Administration of Intravenous Biologics in Patients with Rheumatoid Arthritis

    Sayaka Furukawa1, Sho Fukui 1, Sakura Tamaki 2, Tomoko Nakasone 3 and Masato Okada 4, 1St.Luke's International Hospital, Chuo-ku, Tokyo, Japan, 2St. Luke's International Hospital, Chuo-ku, Japan, 3St. Luke's International Hospital, Chuo-ku, Tokyo, Japan, 4St. Luke's International Hospital, Tokyo, Japan

    Background/Purpose: Biologics are widely used as treatment for rheumatoid arthritis (RA), and pre-administration screening of active infection is imperative for the safety use. There is…
  • Abstract Number: 277 • 2019 ACR/ARP Annual Meeting

    Efficacy of a Counselling Program to Promote Physical Activity in People with Inflammatory Arthritis

    Linda Li1, Hui Xie 2, Na Lu 3, Chris Shaw 4, Diane Gromala 4, Catherine L. Backman 5, Johnathan Tam 6, Noonan Gregory 7, Alison Hoens 1, Anne Townsend 8 and Lynne Feehan 1, 1University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada and Simon Fraser University, Vancouver, BC, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Simon Fraser University, Surrey, BC, Canada, 5University of British Columbia, Vancouver, Canada, 6Arthritis Research Canada, Richmond, BC, Canada, 7Vancouver General Hospital, Vancouver, BC, Canada, 8Lancaster University, Lancaster, United Kingdom

    Background/Purpose: Being physically active is key to successful management in people with inflammatory arthritis (IA). This study aimed to assess efficacy of a physical activity…
  • Abstract Number: 278 • 2019 ACR/ARP Annual Meeting

    Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting

    Jun Chu1, Elaine Poncio 2, Yenealem Temesgen-Oyelakin 2, Michael Davis 3, Isabel Ochoa-Navas 2, Sarthak Gupta 4, Zerai Manna 2, Marquis Chapman 1, Eileen Chu 5, Aidan Donnellan 6 and Sarfaraz Hasni 7, 1National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, 2NIAMS/NIH, Bethesda, 3NIAMS/NIH, Bethesda, MD, 4Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, 5National Institutes of Health, Derwood, MD, 6National Institutes of Health, Bethesda, 7NIAMS, National Institutes of Health, Bethesda, MD

    Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according…
  • Abstract Number: 279 • 2019 ACR/ARP Annual Meeting

    Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases

    Keith Colaco1, Elsie Nguyen 2, Shadi Akhtari 3, Paula Harvey 3 and Lihi Eder 4, 1University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Women's College Hospital, Toronto, ON, Canada, 4Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

    Background/Purpose: The value of non-invasive vascular imaging for cardiovascular (CV) risk stratification of patients with inflammatory rheumatic diseases is unclear. Measures of atherosclerosis including coronary…
  • Abstract Number: 280 • 2019 ACR/ARP Annual Meeting

    Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial

    Ulf Sundin1, Anna-Birgitte Aga 2, Øivind Skare 3, Lena Nordberg 3, Till Uhlig 4, Hilde Hammer 3, Désirée van der Heijde 5, Tore Kvien 4, Siri Lillegraven 6 and Espen Haavardsholm 4, 1Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway. University of Oslo, Oslo, Norway, Oslo, Oslo, Norway, 2Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Oslo, Norway, 3Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway, 4Diakonhjemmet Hospital, Dept. of Rheumatology / University of Oslo, Faculty of Medicine, Oslo, Norway, 5Leiden University Medical Center, Leiden, Netherlands, 6Diakonhjemmet Hospital, Dept. of Rheumatology, Oslo, Norway

    Background/Purpose: It has been debated whether treatment outcomes in early RA would be improved by targeting imaging remission, assessed by ultrasound or MRI, in addition…
  • Abstract Number: 281 • 2019 ACR/ARP Annual Meeting

    Frequency of Ultrasound Features of Knee Osteoarthritis and Their Association with Radiographic Features and Symptoms in a Community-Based Cohort

    Nadiya Yerich1, Carolina Alvarez 2, Todd Schwartz 3, Sue Savage-Guin 2, Catherine Bakewell 4, Minna Kohler 5, Janice Lin 6, Jonathan Samuels 7 and Amanda Nelson 2, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 3University of North Carolina at Chapel Hill Department of Biostatistics, Chapel Hill, NC, 4Intermountain Medical Center, Salt Lake City, UT, 5MGH, Boston, 6Stanford University, Palo Alto, CA, 7NYU Langone Medical Center, New Yort, NY

    Background/Purpose: To evaluate the frequency and associations of osteoarthritis (KOA) features on knee ultrasound (KUS) in a community-based cohort study with radiographic and symptomatic data…
  • Abstract Number: 282 • 2019 ACR/ARP Annual Meeting

    Ultrasound Is More Sensitive Compared to Conventional Radiography to Detect Joint Erosions in ACPA-positive Patients with Musculoskeletal Pain

    Michael Ziegelasch1, Emma Eloff 2, Hilde Hammer 3, Jan Cedergren 4, Klara Martinsson 5, Åsa Reckner 4, Thomas Skogh 2 and Alf Kastbom 2, 1Department of Rheumatology, Linkoping, Sweden, 2Department of Clinical and Experimental Medicine, Linkoping, Sweden, 3Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway, 4Rheumatology Department, Linkoping, Sweden, 5Linköping University, Linköping, Sweden

    Background/Purpose: Circulating anti-citrullinated protein antibodies (ACPA) are associated with an increased risk of developing rheumatoid arthritis (RA), particularly in patients with erosive disease. We previously…
  • Abstract Number: 283 • 2019 ACR/ARP Annual Meeting

    Can Synovial Hypertrophy in the Feet Without Doppler Change During Treatment – Results from a Longitudinal Study of Rheumatoid Arthritis Patients Initiating Biological DMARD

    Lene Terslev1, Mikkel Østergaard 2, Joe Sexton 3 and Hilde Hammer 4, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark, 2Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 3Diakonhjemmet Hospital, Dept. of Rheumatology, Oslo, Norway, 4Diakonhjemmet Hospital, Department of Rheumatology, Oslo, Norway

    Background/Purpose: Ultrasound is used to assess disease activity in rheumatoid arthritis (RA). Gray scale (GS) ultrasound shows the synovial hypertrophy (SH) and Doppler the amount…
  • « Previous Page
  • 1
  • …
  • 1152
  • 1153
  • 1154
  • 1155
  • 1156
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology